Navigation Links
Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
Date:4/11/2013

(PRWEB) April 11, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will be exhibiting and presenting at the 2013 Global Formulation and Drug Delivery Summit in Amsterdam, The Netherlands.

Tony Pigeon, one of Patheon’s scientific experts will be present at the show. Tony is the Senior Manager, Global Science and Technology at Patheon. During his more than 30 year career, he has acquired a considerable degree of experience working with big pharmaceuticals and small biotechs. His diverse experience in the field of drug product development ranges from pre-formulation to process validation for a wide range of dosage forms, including tablets, capsules, semi-solids, sterile solution and suspension products, oral solution and suspension products and aerosols.

Other Patheon representatives will also be available to meet at the Global Formulation and Drug Delivery summit exhibit hall from April 23-24, 2013, showcasing several of Patheon’s key service offerings. Learn more by visiting Patheon’s booth during the conference. To schedule a meeting in advance send an email to events(at)patheon(dot)com.

For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a pro
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
2. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
3. Patheon to Present at Informex USA
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. Patheon to Present at 2013 DCAT Week
6. Patheon to Present New Updates in Drug Formulation and Bioavailability
7. NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco
8. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
9. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
10. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
11. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  Pfenex Inc. (NYSE MKT: PFNX), ... of high-value and difficult to manufacture proteins including ... reported financial results for the second quarter ended ... completion of our initial public offering, we have ... product candidates, derived from our proprietary protein expression ...
(Date:8/29/2014)... 29, 2014 The global companion ... in 2019. It is expected to grow at ... and was valued at $1.8 billion in 2013, ... Market Research. , For more information regarding analysis ... , The research report, titled “Companion Diagnostics Market ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... Chairman, Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, ... JASIS on September 5, 2014. JASIS , Asia’s ... September 3-5, 2014, in Makuhari Messe, Japan. , ... New Tools for Bioanalysis from Single Molecules to Single ...
(Date:8/29/2014)... 2014 Local veterinarian, Dr. Keith Clement, ... seeking candidates to participate in an investigational study of ... ultimate goal of this study is to determine if ... or two arthritically affected joints can help reduce pain ... for the current investigational study must be older than ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Health, a three-hospital health system providing care ... information management system provided by Surgical Information ... seamlessly into the hospitals, existing Siemens Soarian® ... safety and drive business results. ...
... September 29, 2010 ... ... var ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... his significant and global contributions to clean water and ... his commitment to invention and the pursuit of discovery, ... degree from Stevens Institute of Technology at the university,s ... Meng, a professor in the Charles V. Schaefer, Jr. ...
Cached Biology Technology:Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 2Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 4InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 2InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 3InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 4InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 5InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 6InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 7InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 8InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 9InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010 10Xiaoguang Meng receives honorary master of engineering from Stevens 2Xiaoguang Meng receives honorary master of engineering from Stevens 3
(Date:9/2/2014)... truth; everyone has a tipping point. We all want to ... benefit is great enough. Now, scientists have confirmed the area ... , The result was published online this week in ... honest, even if lying is beneficial," said Lusha Zhu, the ... Virginia Tech Carilion Research Institute , where she works with ...
(Date:9/2/2014)... Sam Kean stops by Reactions this week to debunk ... that, despite what "Shark Week" may lead you to ... http://youtu.be/KhFygIoW_MA . , Kean,s book, "The Disappearing Spoon: ... History of the World from the Periodic Table of ... 10-episode video series produced for the newly launched American ...
(Date:9/2/2014)... for eating anything, including each other, camel crickets are ... Carolina State University finds that non-native camel cricket species ... , "The good news is that camel crickets don,t ... says Dr. Mary Jane Epps, a postdoctoral researcher at ... the research. , The research stems from a chance ...
Breaking Biology News(10 mins):Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4Researchers find Asian camel crickets now common in US homes 2
... Johns Hopkins researchers report that two proteins best known ... the liver into a sugar-producing factory when food is ... damaging problem in people with diabetes, the proteins' interaction ... the disease, the researchers say. , Under normal circumstances, ...
... the immune system uses to label foreign invaders as ... system can brand foreign proteins by chemically modifying their ... cells known as lymphocytes would recognize the trespassers and ... T cells need to see these types of modifications ...
... a close relative of the Formosan "super termite" that's ... become established in South Florida, according to University of ... pest in tropical areas such as Brazil and the ... threat to Florida until now," said Nan-Yao Su, a ...
Cached Biology News:Future diabetes drugs may target new protein interaction 2Future diabetes drugs may target new protein interaction 3Newly Discovered 'Branding' Process Helps Immune System Cells Pick Their Fights 2Newly Discovered 'Branding' Process Helps Immune System Cells Pick Their Fights 3Cousin of Asian super termite invades Florida 2
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Human Serpin A3 MAb (Clone 213907)...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Human SorCS1 Affinity Purified Polyclonal Ab Protein Family: Neurotrophins...
Biology Products: